Bhadhuri, A., Insinga, R., Guggisberg, P., Panje, C. and Schwenkglenks, M. (2019) “Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland”, Swiss Medical Weekly, 149(5152), p. w20170. doi: 10.4414/smw.2019.20170.